CASTLE BIOSCIENCES INC
For the period ended Feb 28, 2024. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Feb 28, 2024 · Filed Feb 28, 2024
Use the contents to explore the available documents and sections.
CSTL$32.52-4.9%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Three Months EndedDecember 31, | Twelve Months EndedDecember 31, | |||
|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | |
| (unaudited) · (unaudited) | ||||
| NET REVENUES | $66,120 | $38,338 | $219,788 | $137,039 |
| OPERATING EXPENSES AND OTHER OPERATING INCOME | ||||
| Cost of sales (exclusive of amortization of acquired intangible asset) | 12,423 | 9,520 | 44,982 | 32,009 |
| Research and development | 12,994 | 11,309 | 53,618 | 44,903 |
| Selling, general and administrative | 44,090 | 38,426 | 180,152 | 143,003 |
| Amortization of acquired intangible assets | 2,271 | 2,215 | 9,013 | 8,266 |
| Change in fair value of contingent consideration | — | (300) | — | (18,287) |
| Total operating expenses, net | 71,778 | 61,170 | 287,765 | 209,894 |
| Operating loss | (5,658) | (22,832) | (67,977) | (72,855) |
| Interest income and other non-operating income | 3,119 | 2,275 | 10,623 | 3,968 |
| Interest expense | (2) | (4) | (11) | (17) |
| Loss before income taxes | (2,541) | (20,561) | (57,365) | (68,904) |
| Income tax expense (benefit) | 39 | 57 | 101 | (1,766) |
| Net loss | $(2,580) | $(20,618) | $(57,466) | $(67,138) |
| Loss per share, basic and diluted | $(0.10) | $(0.78) | $(2.14) | $(2.58) |
| Weighted-average shares outstanding, basic and diluted | 27,030 | 26,400 | 26,802 | 26,054 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.